The details of a synthesis method for biologically relevant hydrated calcium pyrophosphates (CPPs, Ca 2 P 2 O 7 ·nH 2 O) has been elucidated. Control of the pH (from 3.6 to 5.8) and the temperature (from 25 to 90°C) during the synthesis enabled the preparation of four pure CPP phases within one hour without intermediates: monoclinic and triclinic calcium pyrophosphate dihydrate (CPPD, Ca 2 P 2 O 7 ·2H 2 O), which are the two CPP phases detected in vivo in joints of arthritic patients, monoclinic tetrahydrate β (CPPT, Ca 2 P 2 O 7 ·4H 2 O) and an amorphous phase (a-CPP, Ca 2 P 2 O 7 ·nH 2 O). Four domains corresponding to the four different phases of hydrated calcium pyrophosphate were identified; a-CPP was synthesised over a very wide pH and temperature range (up to 90°C) within the domain of synthesis conditions explored, including physiological conditions (pH 7.4 and 37°C). The as-synthesised hydrated CPP phases were characterised by complementary techniques (powder X-ray diffraction, FTIR and Raman spectroscopy, scanning electron microscopy and thermogravimetry) and chemical analyses. Rietveld refinement analyses of the as-synthesised crystalline phases were performed, and[a] CIRIMAT,